Also, the genetic and pharmacological inhibition of TREK-1 alters depression-related behaviors and neuronal plasticity in mice, indicating the significance of these channels as therapeutic targets for neuronal disorders [20]. The gene discussed is KCNK2; the disease is depressive symptom measurement.